ACIL KONTRASEPSIYON PDF
English Turkish online dictionary Tureng, translate words and terms with different pronunciation options. English Turkish online dictionary Tureng, translate words and terms with different pronunciation options. emergency contraception method acil kontrasepsiyon. acil kontrasepsiyon yöntemleri. Meanings of “acil kontrasepsiyon yöntemleri” in English Turkish Dictionary: 1 result(s). Category, Turkish, English. Medical.
|Published (Last):||28 January 2012|
|PDF File Size:||8.62 Mb|
|ePub File Size:||17.97 Mb|
|Price:||Free* [*Free Regsitration Required]|
N Engl J Med. With the introduction of scopolamine and particularly nicotine, patches have become an accepted, mainstream method of drug delivery.
The first hormone-containing patches were introduced for estrogen replacement in Today, patches that deliver both estrogen and progestin for hormone replacement are available. Because transdermal delivery does not rely on gastrointestinal absorption, there is no potential loss of a dose in the event of vomiting or diarrhea.
Because of the method of delivery, the hormones bypass the gastrointestinal tract and are not lost during gastrointestinal upset. Pharmacokinetics of norelgestromin and ethinyl estradiol from two consecutive contraceptive patches.
Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants.
Abrams LS, et al. Creasy GW, et al. Description The transdermal contraceptive system is based on acul day 4-week cycle and the delivery of a continuous dose of estrogen and progestin through the skin and subcutaneous kontraxepsiyon for absorption into the adil. Three patches are used during the day cycle for a total of 21 days.
Each patch lasts for seven days; a new patch is applied each week to a unique area except for the breast and the old patch is discarded. To maximize effectiveness, each patch should be applied on the same day of the week.
During week four, no patch is worn and withdrawal bleeding is expected. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: Efficacy and safety of a transdermal contraceptive system.
Smallwood GH, et al. The patch is applied to the buttocks, upper outer arm, lower abdomen, or upper torso excluding the breast. Each patch should be applied to a unique area, which could be near the site of the last patch. New developments in contraception. J Pediatr Adolesc Gynecol. With typical use, the efficacy of the patch Weekly application encourages consistent and correct use of the patch, and its presence is easily verified.
It does not require vaginal insertion like the vaginal ring or some of the barrier methods of contraception e. Finally, the patch does not provide protection against sexually transmitted infections or HIV. Zieman M, et al. Kontdasepsiyon of the trials were multicenter, used open-label contraceptives, and had similar study designs.
There were 12 method-failure pregnancies and 3 user-failure pregnancies in 3, women treated for 22, cycles. The overall probability of pregnancy through 13 cycles was 0. Comparison of efficacy, cycle control, compliance, and safety in users of a contraceptive patch vs an oral contraceptive kontrasspsiyon ].
Int J Gynaecol Obstet.
Audet MC, et al. Hedon B, et al. Most Common Adverse Events Audet et al. In this study, the adverse events reported by the study participants were similar between the group using the transdermal contraceptive patch and that using the oral contraceptive, with the exception of application-site reactions and breast discomfort.
The incidence of breast discomfort was higher for the patch group than for the oral contraceptive group during cycles 1 and 2 For cycles 3 to 13, the by-cycle incidence of breast symptoms was similar between the two treatment groups. After two to eight weeks of synchronization by treatment with a combined oral contraceptive, the subjects were randomized to days of treatment with one of the three contraceptives being compared. The highest mean peak concentration Cmax was seen in the contraceptive pill group, which was 4.
The mean Cmax for the patch was 2. Inthe U. Food and Drug Kontrasepdiyon approved updated labeling information for the Ortho Evra patch to kontrasepsiton healthcare providers and patients about the increased levels of estrogen that users of the patch are exposed to in comparison to oral contraceptive users.
AİLE PLANLAMASI VE ACİL KONTRASEPSİYON.
Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: Although it has been hypothesized that the patch confers an increased risk of these aciil because it contains a greater amount of estradiol than other hormonal contraceptive methods, studies of transdermal patch usage and risk of venous thromboembolic events have given conflicting results. Two case-control studies used electronic healthcare claims data to compare the risk of venous thromboembolic events in women between the ages of 15 and 44 years who used either the transdermal patch or a norgestimate-containing oral contraceptive.
In the study by Jick et al.
The odds ratio for current users of the patch was 0. In the study by Cole et al. Overall, there was a two-fold increase in the risk of venous thromboembolic events among users of the patch when compared with users of the oral contraceptive OR 2.
Differences in study design may explain the conflicting results of these studies. Kontrasepsiyonn example, the study by Jick et al.
There were also differences in the patient selection processes, which may have influenced the outcomes. The study by Jick et al. As kontrasepisyon, prior users of norgestimate-containing oral contraceptives were excluded from the norgestimate group but were permitted in the transdermal patch group.
These participants with past hormonal contraceptive experience may have attenuated the incidence of venous thromboembolic events in the transdermal group since the risk of these events is greatest in the kontraseepsiyon phases of use.
Kontrasepsiyonda Güncel Görüşler – ppt indir
In contrast, participants in the study by Cole et al. Food and Drug Administration FDA approved updated labeling information for the Ortho Evra patch to alert healthcare providers and patients of these epidemiologic studies.
The FDA also recommend that women with risk factors for venous thromboembolic events discuss the use of the Ortho Evra patch with their healthcare provider because it may be associated with an increased risk of these events in some women. Women should be counseled about the risk of venous thromboembolic events that is associated with the use of any combined contraceptive product, and women who have risk factors for these events should consider using nonhormonal contraceptive methods.
Women who are immobilized due to surgery or injury should discontinue the Ortho Evra patch because of the associated risk for venous thromboembolic events. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of accil estradiol.
Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Jick SS, et al. A treatment cycle consists of kpntrasepsiyon consecutive application of three patches for seven days each, followed by a seven-day, patch-free phase.
Women who use this method have greater compliance when compared with women who use oral contraceptives. Food and Drug Administration FDA approved updated labeling information for the Ortho Evra patch to alert healthcare providers and patients of two recent epidemiologic studies.
The label has recommended and continues to recommend that women with concerns or risk factors for thromboembolic disease talk with their healthcare provider about using Ortho Evra versus other contraceptive options because it may be associated with an increased risk of these events in some women.
Mechanisms of Action Aciil primary method of action in intrauterine contraceptives IUDs is to prevent the fertilization of ova, which is supported by the low rate of ectopic pregnancies among users. A high concentration of levonorgestrel in the endometrium leads to kkntrasepsiyon endometrial atrophy that, in turn, results in a substantial reduction in menstrual flow or in amenorrhea in some users.
Changes also occur in the endometrium that could interfere with the implantation of a fertilized ovum, which explains why this device is particularly effective as a method for emergency contraception. Effects of various IUDs on the composition of cervical mucus. Copper containing, framed afil devices for contraception.